Alagebrium, a product of Alteon drug discovery and development program the the treatment of diastolic heart failure. This disease represents a fast growing market of unmet medical need, particularly common in diabetic patients. Web site.ted.has shown and relevant clinical activity in two Phase 2 clinical trials in heart failure. As in animal models of congestive heart failure and nephropathy, has, inter alia, at ca.000 alagebrium Phase 1 and Phase Phase 1 and Phase 2 clinical trials significant significant human security database were tested.
About ESRD and peritoneal dialysisend – stage renal disease is a condition in which the kidneys no longer function, which show an increase of waste products in the body Latest about 10-15 about 10-15. percent of the more than 200,000 Americans undergo weekly dialysis for ESRD are undergoing peritoneal dialysis, a method of dialysis the same principle as the same principle as hemodialysis, but uses the patient’s peritoneum to filter waste products instead of a machine. It is less expensive and more effective than hemodialysis by some measures in the beginning. Nevertheless, it is time consuming, by by abdominal infections and characterized by a gradual deterioration of efficacy, thought to be associated with the accumulation of AGEs.
Alteon Inc.Of POM Wonderful contradicted FTC charges against to.
Pomegranates are Dining – very nourishing product, developed by nature. There POM products in fact can offer a promise improved health, we believe it is important share that research results as they become available. This is especially as products not bear the with medicines with drugs. It is shameful that the Government of has do not able to understand them fundamental distinction, and instead to waste taxpayers resources to pursue pomegranate. To date, more than 55 studies of POM products, including 19 clinical trial have been published in peer-reviewed journals. Results were encouraging and many additional studies are in progress.